Your browser doesn't support javascript.
loading
Glucose Control, Disease Burden, and Educational Gaps in People With Type 1 Diabetes: Exploratory Study of an Integrated Mobile Diabetes App.
Tack, Cornelis J; Lancee, Gerardus J; Heeren, Barend; Engelen, Lucien Jlpg; Hendriks, Sandra; Zimmerman, Lisa; De Massari, Daniele; van Gelder, Marleen Mhj; van de Belt, Tom H.
Afiliación
  • Tack CJ; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • Lancee GJ; Radboud REshape Innovation Center, Radboud University Medical Center, Nijmegen, Netherlands.
  • Heeren B; Radboud REshape Innovation Center, Radboud University Medical Center, Nijmegen, Netherlands.
  • Engelen LJ; Radboud REshape Innovation Center, Radboud University Medical Center, Nijmegen, Netherlands.
  • Hendriks S; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • Zimmerman L; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • De Massari D; Royal Philips, Eindhoven, Netherlands.
  • van Gelder MM; Radboud REshape Innovation Center, Radboud University Medical Center, Nijmegen, Netherlands.
  • van de Belt TH; Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, Netherlands.
JMIR Diabetes ; 3(4): e17, 2018 Nov 23.
Article en En | MEDLINE | ID: mdl-30470680
BACKGROUND: Self-monitoring and self-management, crucial for optimal glucose control in type 1 diabetes, requires many disease-related decisions per day and imposes a substantial disease burden on people with diabetes. Innovative technologies that integrate relevant measurements may offer solutions that support self-management, decrease disease burden, and benefit diabetes control. OBJECTIVE: The objective of our study was to evaluate a prototype integrated mobile phone diabetes app in people with type 1 diabetes. METHODS: In this exploratory study, we developed an app that contained cloud-stored log functions for glucose, carbohydrates (including a library), insulin, planned exercise, and mood, combined with a bolus calculator and communication functions. Adults with diabetes tested the app for 6 weeks. We assessed the feasibility of app use, user experiences, perceived disease burden (through questionnaires), insulin dose and basal to bolus ratio, mean glucose level, hemoglobin A1c, and number of hypoglycemic events. RESULTS: A total of 19 participants completed the study, resulting in 5782 data entries. The most frequently used feature was logging blood glucose, insulin, and carbohydrates. Mean diabetes-related emotional problems (measured with the Problem Areas in Diabetes scale) scores decreased from 14.4 (SD 10.0) to 12.2 (SD 10.3; P=.04), and glucose control improved, with hemoglobin A1c decreasing from 7.9% (mean 62.3, SD 8 mmol/mol) to 7.6% (mean 59.8, SD 7 mmol/mol; P=.047). The incidence of hypoglycemic events did not change. Participants were generally positive about the app, rating it as "refreshing," and as providing structure by reinforcing insulin-dosing principles. The app revealed substantial knowledge gaps. Logged data enabled additional detailed analyses. CONCLUSIONS: An integrated mobile diabetes app has the potential to improve diabetes self-management and provide tailored educational support, which may decrease disease burden and benefit diabetes control.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: JMIR Diabetes Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: JMIR Diabetes Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Canadá